MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema

Clinical trial NCT04187443 · RECRUITING

Trial details

NCT number: NCT04187443
Sponsor: Shenzhen MingSight Relin Pharmaceuticals Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetic Macular Edema Macular Edema Type 2 Diabetes With Diabetic Macular Edema Type 1 Diabetes With Diabetic Macular Edema Diabetic Retinopathy

Start date: 2020-06-02
Primary completion: 2026-10-30
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.